Subscribe To
Achieve life sciences reports statistically significant smoking cessation benefit for cytisinicline in second, confirmatory phase 3 clinical trial
ORCA-3 demonstrated statistically significant topline results in primary and secondary smoking cessatio...
May 23, 2023, 10:00 am
Achieve life sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results
Achieve Life Sciences Inc. ACHV, +12.88% said Tuesday a second confirmatory late-stage trial of its cytisinicline for quitting smoking and nicotine de...
May 23, 2023, 6:12 am
Novo nordisk says trial of oral weight-loss drug shows significant result
Novo Nordisk's trial of the oral version of its weight-loss drug semaglutide has shown statistically si...
May 22, 2023, 10:22 am
Apnimed presented positive phase 2b results on ad109, an investigational oral drug for obstructive sleep apnea, for the first time at ats 2023
— New MARIPOSA Study Data Showed AD109 statistically Significantly Improved Both Objective and Subjec...
May 21, 2023, 2:00 pm
Travere therapeutics stock slides 35% after announcing disappointing results from 2-year trial of kidney drug
Travere Therapeutics Inc.'s stock TVTX tumbled 35% Tuesday, after the company said data from a two-year study of a kidney drug failed to show a ...
May 2, 2023, 12:50 pm
Merck and eisai report disappointing results from trials of combination treatment for melanoma and colorectal cancer
Merck MRK and its Japanese partner Eisai said Friday they are discontinuing the Phase 3 LEAP-003 trial evaluating Keytruda plus Lenvima for the first-...
April 7, 2023, 7:02 am
Travere therapeutics announces interim analysis from the phase 3 protect study of filspari™ (sparsentan) in iga nephropathy published in the lancet and presented at world congress of nephrology 2023
FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared...
April 1, 2023, 8:30 am
Gilead (gild) announces os data on yescarta from zuma-7 study
Gileads Yescarta shows statistically significant improvement in overall survival for initial treatment ...
March 22, 2023, 4:01 pm
Karuna's stock is up after schizophrenia drugs meets primary endpoint in clinical trial
Shares of Karuna Therapeutics Inc. KRTX, +1.21% rallied about 14% in premarket trading on Monday after the company said its experimental treatment for...
March 20, 2023, 7:46 am
Edesa biotech to present favorable dermatitis drug results at american academy of dermatology association annual meeting
TORONTO, ON / ACCESSWIRE / March 16, 2023 / Edesa Biotech, Inc. announced today that the company has been selected to present clinical trial data from...
March 16, 2023, 4:10 pm
New analyses of sotagliflozin showing time to clinical benefit presented at the american college of cardiology’s 72nd annual scientific session together with world heart federation’s world congress of
statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally co...
March 4, 2023, 5:00 pm
New analyses of sotagliflozin showing time to clinical benefit presented at the american college of cardiology’s 72nd annual scientific session together with world heart federation’s world congress of
statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally co...
March 4, 2023, 5:00 pm
New analyses of sotagliflozin showing time to clinical benefit presented at the american college of cardiology’s 72nd annual scientific session together with world heart federation’s world congress of
statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally co...
March 4, 2023, 5:00 pm
New analyses of sotagliflozin showing time to clinical benefit presented at the american college of cardiology’s 72nd annual scientific session together with world heart federation’s world congress of
statistically significant reduction in the risk for the primary outcome on Day 27 Findings generally co...
March 4, 2023, 5:00 pm
Altamira therapeutics to report bentrio clinical data, in house dust mite and grass pollen allergic rhinitis, at feb. 25 aaaai annual meet-ing
House dust mite study shows statistically significant reduction in symptoms vs. no protection Grass pol...
February 14, 2023, 8:47 am
Achieve life sciences: all eyes on phase 3 data for smoking cessation drug
ORCA-2 phase 3 trial was a success where Cytisinicline has shown statistically significant improvement ...
January 28, 2023, 11:45 pm
Phathom pharmaceuticals announces positive topline results from phase 3 phalcon-nerd-301 trial evaluating daily dosing of vonoprazan for symptomatic non-erosive gastroesophageal reflux disease (nerd)
Both vonoprazan 10 mg and 20 mg doses met the primary endpoint and showed highly statistically signific...
January 8, 2023, 11:00 pm
Atai life sciences shares plummet as r-ketamine candidate fails to meet primary endpoint in phase 2a trial
atai Life Sciences (NASDAQ:ATAI) shares tumbled more than 40% in pre-market trading on Friday after the company reported disappointing results from it...
January 6, 2023, 9:46 am
Moderna shares get a boost from merck vaccine combo
Moderna Therapeutics Inc (NASDAQ:MRNA) shares rallied after the biotechnology firm told investors that a trial that combined its investigational cance...
December 13, 2022, 12:49 pm
Rba says its pandemic cheap lending policy to business failed (sort of)
The Reserve Bank of Australia has published a research paper on its cheap lending facility introduced as part of its Covid policy response. It conc...
December 13, 2022, 3:18 am